Attention-deficit/hyperactivity disorder in older adults: prevalence and possible connections to mild cognitive

Nikki Ivanchak1, Kristen Fletcher, Gregory A Jicha

  • 1Department of Neurology and the Sanders-Brown Center on Aging, University of Kentucky College of Medicine, Lexington, KY, USA.

Insights

Persistent ADHD in older adults may mimic mild cognitive impairment (MCI), potentially delaying diagnosis. This review explores whether ADHD causes MCI or if they are merely associated, finding both possibilities plausible.

Area of Science:

  • Neuroscience
  • Geriatric Medicine
  • Psychiatry

Background:

  • Attentional deficits are early signs of neurodegenerative diseases, often presenting as mild cognitive impairment (MCI).
  • Adult Attention-Deficit/Hyperactivity Disorder (ADHD) in older individuals can be misdiagnosed as MCI.
  • The underlying mechanisms of ADHD may influence the development of late-life neurodegenerative conditions.

Purpose of the Study:

  • To review the relationship between ADHD and MCI in the geriatric population.
  • To investigate the potential causality versus confounding factors in the association between ADHD and MCI.
  • To evaluate the diagnostic implications of persistent ADHD in elderly individuals.

Main Methods:

  • Literature review of studies examining ADHD and MCI in older adults.
  • Analysis of potential neurobiological links between ADHD and neurodegeneration.
  • Discussion of clinical presentation and diagnostic challenges.

Main Results:

  • Persistent ADHD in the elderly can be mistaken for MCI.
  • ADHD's neurobiological features might contribute to developing new neurodegenerative diseases later in life.
  • The association between ADHD and MCI is complex, with causality and confounding as viable explanations.

Conclusions:

  • Distinguishing between ADHD and MCI in geriatric patients is crucial for accurate diagnosis and treatment.
  • Further research is needed to elucidate the precise relationship between ADHD and late-life neurodegenerative diseases.
  • Understanding this link can improve the management of cognitive decline in aging populations.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...